{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,25]],"date-time":"2025-09-25T16:44:03Z","timestamp":1758818643566},"reference-count":18,"publisher":"Springer Science and Business Media LLC","issue":"3","license":[{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"},{"start":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T00:00:00Z","timestamp":1564358400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Hepatology Rep"],"published-print":{"date-parts":[[2019,9]]},"DOI":"10.1007\/s11901-019-00479-9","type":"journal-article","created":{"date-parts":[[2019,7,29]],"date-time":"2019-07-29T02:02:49Z","timestamp":1564365769000},"page":"310-315","update-policy":"http:\/\/dx.doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":1,"title":["Chronic Hepatitis B in US Veterans"],"prefix":"10.1007","volume":"18","author":[{"given":"Patrik","family":"Garren","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Marina","family":"Serper","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"297","published-online":{"date-parts":[[2019,7,29]]},"reference":[{"issue":"12","key":"479_CR1","doi-asserted-by":"publisher","first-page":"926","DOI":"10.7326\/L14-5036","volume":"161","author":"LI Backus","year":"2014","unstructured":"Backus LI, Belperio PS, Loomis TP, Han SH, Mole LA. Screening for and prevalence of hepatitis B virus infection among high-risk veterans under the care of the U.S. Department of Veterans Affairs: a case report. Ann Intern Med. 2014;161(12):926\u20138.","journal-title":"Ann Intern Med"},{"issue":"5","key":"479_CR2","doi-asserted-by":"publisher","first-page":"319","DOI":"10.7326\/0003-4819-154-5-201103010-00006","volume":"154","author":"GN Ioannou","year":"2011","unstructured":"Ioannou GN. Hepatitis B virus in the United States: infection, exposure, and immunity rates in a nationally representative survey. Ann Intern Med. 2011;154(5):319\u201328.","journal-title":"Ann Intern Med"},{"issue":"RR-8","key":"479_CR3","first-page":"1","volume":"57","author":"CM Weinbaum","year":"2008","unstructured":"Weinbaum CM, Williams I, Mast EE, Wang SA, Finelli L, Wasley A, et al. Recommendations for identification and public health management of persons with chronic hepatitis B virus infection. MMWR Recomm Rep. 2008;57(RR-8):1\u201320.","journal-title":"MMWR Recomm Rep"},{"issue":"2","key":"479_CR4","doi-asserted-by":"publisher","first-page":"252","DOI":"10.1093\/cid\/cix295","volume":"65","author":"AJ Noska","year":"2017","unstructured":"\u2022 Noska AJ, Belperio PS, Loomis TP, O'Toole TP, Backus LI. Prevalence of human immunodeficiency virus, hepatitis C virus, and hepatitis B virus among homeless and nonhomeless United States Veterans. Clin Infect Dis. 2017;65(2):252\u20138 Important retrospective study identifying homelessness as a risk factor for HBV among veterans.","journal-title":"Clin Infect Dis"},{"issue":"1","key":"479_CR5","doi-asserted-by":"publisher","first-page":"e14\u20137","DOI":"10.1097\/QAI.0000000000000941","volume":"72","author":"D Bhattacharya","year":"2016","unstructured":"Bhattacharya D, Tseng CH, Tate JP, Lo Re V 3rd, Gibert CL, Butt AA, et al. Isolated hepatitis B core antibody is associated with advanced hepatic fibrosis in HIV\/HCV infection but not in HIV infection alone. Journal of acquired immune deficiency syndromes (1999). 2016;72(1):e14\u20137.","journal-title":"Journal of acquired immune deficiency syndromes (1999)"},{"issue":"6","key":"479_CR6","doi-asserted-by":"publisher","first-page":"1471\u201382.e5","DOI":"10.1053\/j.gastro.2015.07.056","volume":"149","author":"LA Beste","year":"2015","unstructured":"\u2022\u2022 Beste LA, Leipertz SL, Green PK, Dominitz JA, Ross D, Ioannou GN. Trends in burden of cirrhosis and hepatocellular carcinoma by underlying liver disease in US veterans, 2001\u20132013. Gastroenterology. 2015;149(6):1471\u201382.e5 quiz e17\u20138. Important study regarding the prevalence and trends in advanced liver disease from all causes, including HBV, in the veteran population.","journal-title":"Gastroenterology"},{"issue":"6","key":"479_CR7","doi-asserted-by":"publisher","first-page":"1871","DOI":"10.1002\/hep.27337","volume":"60","author":"RL Kruse","year":"2014","unstructured":"Kruse RL, Kramer JR, Tyson GL, Duan Z, Chen L, El-Serag HB, et al. Clinical outcomes of hepatitis B virus coinfection in a United States cohort of hepatitis C virus-infected patients. Hepatology (Baltimore, Md). 2014;60(6):1871\u20138.","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"2","key":"479_CR8","doi-asserted-by":"publisher","first-page":"355","DOI":"10.1016\/j.jhep.2016.09.013","volume":"66","author":"M Chayanupatkul","year":"2017","unstructured":"Chayanupatkul M, Omino R, Mittal S, Kramer JR, Richardson P, Thrift AP, et al. Hepatocellular carcinoma in the absence of cirrhosis in patients with chronic hepatitis B virus infection. J Hepatol. 2017;66(2):355\u201362 \u2022.","journal-title":"J Hepatol"},{"issue":"8","key":"479_CR9","doi-asserted-by":"publisher","first-page":"2462","DOI":"10.1111\/j.1572-0241.2001.04054.x","volume":"96","author":"HB El-Serag","year":"2001","unstructured":"El-Serag HB, Richardson PA, Everhart JE. The role of diabetes in hepatocellular carcinoma: a case-control study among United States Veterans. Am J Gastroenterol. 2001;96(8):2462\u20137.","journal-title":"Am J Gastroenterol"},{"issue":"3","key":"479_CR10","doi-asserted-by":"publisher","first-page":"586","DOI":"10.1016\/j.jhep.2015.04.025","volume":"63","author":"T Kushner","year":"2015","unstructured":"\u2022 Kushner T, Serper M, Kaplan DE. Delta hepatitis within the Veterans Affairs medical system in the United States: prevalence, risk factors, and outcomes. J Hepatol. 2015;63(3):586\u201392 Important study identifying Delta Hepatitis as an risk factor for hepatocellular carcinoma.","journal-title":"J Hepatol"},{"issue":"19","key":"479_CR11","doi-asserted-by":"publisher","first-page":"4732","DOI":"10.3748\/wjg.v22.i19.4732","volume":"22","author":"CM Hunt","year":"2016","unstructured":"Hunt CM, Beste LA, Lowy E, Suzuki A, Moylan CA, Tillmann HL, et al. Veterans health administration hepatitis B testing and treatment with anti-CD20 antibody administration. World J Gastroenterol. 2016;22(19):4732\u201340 \u2022.","journal-title":"World J Gastroenterol"},{"issue":"6","key":"479_CR12","doi-asserted-by":"publisher","first-page":"1551","DOI":"10.1007\/s10620-018-5042-3","volume":"63","author":"R Shah","year":"2018","unstructured":"\u2022 Shah R, Ho EY, Kramer JR, Richardson P, Sansgiry S, El-Serag HB, et al. Hepatitis B virus screening and reactivation in a national VA cohort of patients with inflammatory bowel disease treated with tumor necrosis factor antagonists. Digestive diseases and sciences. 2018;63(6):1551\u20137 Informative study showing the current use of anti- tumor necrosis factor therapy, HBV screening rates and reactivation.","journal-title":"Digestive diseases and sciences"},{"key":"479_CR13","unstructured":"US Food and Drug Administration. FDA Drug Safety Communication: FDA warns about the risk of hepatitis B reactivating in some patients treated with direct-acting antivirals for hepatitis C. 2016. \n                      https:\/\/www.fda.gov\/Drugs\/DrugSafety\/ucm522932.htm\n                      \n                    , Accessed December 31st, 2018."},{"issue":"2","key":"479_CR14","doi-asserted-by":"publisher","first-page":"187","DOI":"10.1111\/jvh.12784","volume":"25","author":"M Serper","year":"2018","unstructured":"\u2022\u2022 Serper M, Forde KA, Kaplan DE. Rare clinically significant hepatic events and hepatitis B reactivation occur more frequently following rather than during direct-acting antiviral therapy for chronic hepatitis C: Data from a national US cohort. J Viral Hepat. 2018;25(2):187\u201397 National cohort study, which provides the prevalence of HBV reactivations, hepatitis, and adverse events with HCV DAA therapy.","journal-title":"J Viral Hepat"},{"issue":"1","key":"479_CR15","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1002\/hep.29135","volume":"66","author":"PS Belperio","year":"2017","unstructured":"\u2022\u2022 Belperio PS, Shahoumian TA, Mole LA, Backus LI. Evaluation of hepatitis B reactivation among 62,920 veterans treated with oral hepatitis C antivirals. Hepatology (Baltimore, Md). 2017;66(1):27\u201336 National cohort study, which provides the prevalence of HBV reactivations, hepatitis, and adverse events with HCV DAA therapy.","journal-title":"Hepatology (Baltimore, Md)"},{"issue":"6","key":"479_CR16","doi-asserted-by":"publisher","first-page":"1774","DOI":"10.1002\/hep.28340","volume":"63","author":"M Serper","year":"2016","unstructured":"\u2022\u2022 Serper M, Choi G, Forde KA, Kaplan DE. Care delivery and outcomes among US veterans with hepatitis B: a national cohort study. Hepatology (Baltimore, MD). 2016;63(6):1774\u201382 National cohort study highlighting critical gaps in the Cascade of care for HBV.","journal-title":"Hepatology (Baltimore, MD)"},{"issue":"6","key":"479_CR17","doi-asserted-by":"publisher","first-page":"867","DOI":"10.1038\/ajg.2014.72","volume":"109","author":"Y Wu","year":"2014","unstructured":"Wu Y, Johnson KB, Roccaro G, Lopez J, Zheng H, Muiru A, et al. Poor adherence to AASLD guidelines for chronic hepatitis B management and treatment in a large academic medical center. Am J Gastroenterol. 2014;109(6):867\u201375.","journal-title":"Am J Gastroenterol"},{"issue":"10","key":"479_CR18","doi-asserted-by":"publisher","first-page":"900","DOI":"10.1097\/MCG.0000000000000806","volume":"51","author":"T Kushner","year":"2017","unstructured":"\u2022 Kushner T, Lam R, Gray DL, Kaplan DE, Serper M. Identifying patient and provider-specific gaps in care among patients with hepatitis B. Journal of clinical gastroenterology. 2017;51(10):900\u20136 Multi-center retrospective study of factors associated with gaps in appropriate follow-up testing and clinical care for HBV.","journal-title":"Journal of clinical gastroenterology"}],"container-title":["Current Hepatology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11901-019-00479-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11901-019-00479-9\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11901-019-00479-9.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,7,27]],"date-time":"2020-07-27T23:51:22Z","timestamp":1595893882000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11901-019-00479-9"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2019,7,29]]},"references-count":18,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2019,9]]}},"alternative-id":["479"],"URL":"https:\/\/doi.org\/10.1007\/s11901-019-00479-9","relation":{},"ISSN":["2195-9595"],"issn-type":[{"value":"2195-9595","type":"electronic"}],"subject":[],"published":{"date-parts":[[2019,7,29]]},"assertion":[{"value":"29 July 2019","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Patrik Garren declares no potential conflicts of interest. Marina Serper reports consulting fees from BioVie, Inc. outside the submitted work.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}]}}